SAI LIFE SCIENCES LIMITED (SAILIFE) Share Price Hits Fresh 52-Week High
- August 5, 2026
- Posted by: Harsh Piplani
- Category: News
SAI LIFE SCIENCES LIMITED Share Price reached a fresh 52-week high of Rs 1,387, rising by 1.51% today. The company’s market capitalisation stands at Rs 28,266.01 crore.
SAI LIFE SCIENCES LIMITED Share Price has reached a fresh 52-week high of Rs 1,387, marking a significant milestone for the company. The stock closed at Rs 1,364.3 previously and opened today at Rs 1,379.35. With a current price of Rs 1,384.95, the stock has risen by 1.51% today. The market capitalisation of SAI LIFE SCIENCES LIMITED is Rs 28,266.01 crore, reflecting its substantial presence in the healthcare sector. This achievement highlights the stock’s upward momentum and investor interest.
SAI LIFE SCIENCES LIMITED Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,384.95 |
| Previous Close | Rs 1,364.3 |
| Today's Change | +Rs 20.65 (+1.51%) |
| Day Open | Rs 1,379.35 |
| Fresh 52-Week High | Rs 1,387 |
| Day Low | Rs 1,355 |
| Current Volume | 90,778 |
| Turnover | Rs 12.57 crore |
| Market Capitalisation | Rs 28,266.01 crore |
SAI LIFE SCIENCES LIMITED (SAILIFE) traded at Rs 1,384.95. versus the previous close of Rs 1,364.3, a rise of 1.51%. The stock opened at Rs 1,379.35, reached Rs 1,387, touched Rs 1,355. Reported volume was 90,778.
Today, SAI LIFE SCIENCES LIMITED Share Price opened at Rs 1,379.35 and reached a high of Rs 1,387, setting a new 52-week peak. The stock’s previous close was Rs 1,364.3, and it experienced a day change of Rs 20.65, equivalent to a 1.51% increase. The day’s low was Rs 1,355, with a turnover of Rs 12.57 crore. The current volume of 90,778 shares indicates active participation, suggesting strong investor interest in the stock.
SAI LIFE SCIENCES LIMITED (SAILIFE) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 28,266.01 crore |
| P/E Ratio | 30.21x |
| P/B Ratio | 0.44x |
| ROE | -2.89% |
| ROCE | -0.26% |
SAI LIFE SCIENCES LIMITED was valued at a P/E ratio of 30.21x, a P/B ratio of 0.44x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.
Profitability and capital efficiency were represented by ROE of -2.89% and ROCE of -0.26%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Benchmark Scope | same sector |
| Company P/E Ratio | 30.21x |
| Benchmark Median P/E | 21.71x |
| Benchmark Average P/E | 71.67x |
| Benchmark P/E Range | 0x to 3,385.56x |
| Company P/B Ratio | 0.44x |
| Benchmark Median P/B | 1.9x |
| Company ROE | -2.89% |
| Benchmark Median ROE | 10.75% |
| Company ROCE | -0.26% |
| Benchmark Median ROCE | 13.29% |
| Company Market Capitalisation | Rs 28,266.01 crore |
| Benchmark Median Market Cap | Rs 136.63 crore |
SAI LIFE SCIENCES LIMITED (SAILIFE) is classified under sector: Healthcare.
SAI LIFE SCIENCES LIMITED (SAILIFE) has a P/E ratio of 30.21x, which is above the benchmark median of 21.71x, a difference of +39.15%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
SAI LIFE SCIENCES LIMITED (SAILIFE) has a ROE of -2.89%, which is below the benchmark median of 10.75%, a difference of -126.88%. SAI LIFE SCIENCES LIMITED (SAILIFE) has a ROCE of -0.26%, which is below the benchmark median of 13.29%, a difference of -101.96%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Dishman Carbogen Amcis Ltd. | DCAL | 2,945.17 | 30.21 | 0.44 | -2.89 | -0.26 |
| Kwality Pharmaceuticals Ltd. | KPL | 2,652.68 | 39.86 | 8.11 | 28.21 | 26.35 |
| Beta Drugs Ltd. | BETA | 2,608.51 | 63.2 | 10 | 18.65 | 22.17 |
| Dr Agarwals Eye Hospital Ltd. | DRAGARWQ | 2,457.9 | 32.25 | 6.65 | -2.6 | 16.92 |
| Sai Parenteral's Ltd. | SAIPARENT | 2,451.51 | 164.6 | 3.04 | 13.9 | 12.97 |
SAI LIFE SCIENCES LIMITED (SAILIFE) has a P/E ratio of 30.21x compared with the displayed peer median of 39.86x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of -2.89% compares with a peer median of 13.9% across the companies shown in the table. ROCE stood at -0.26% versus the displayed peer median of 16.92%, providing a capital-efficiency comparison. SAI LIFE SCIENCES LIMITED (SAILIFE) has a market capitalisation of Rs 28,266.01 crore. Among the 5 peers shown, 0 have a larger market capitalisation.
Why Investors Are Watching SAI LIFE SCIENCES LIMITED
- SAI LIFE SCIENCES LIMITED Share Price reached a fresh 52-week high of Rs 1,387.
- Active trading volume indicates strong investor interest.
- Fundamental analysis shows a mixed valuation picture.
- Sector analysis reveals potential undervaluation in P/B ratio.
- Peer comparison highlights market cap strength but profitability challenges.
About SAI LIFE SCIENCES LIMITED
SAI LIFE SCIENCES LIMITED is a prominent player in the healthcare sector, focusing on providing comprehensive solutions in the pharmaceutical and biotechnology industries. The company engages in research and development, manufacturing, and distribution of a wide range of pharmaceutical products. Its operations are geared towards innovation and quality, catering to both domestic and international markets. With a strong commitment to advancing healthcare, SAI LIFE SCIENCES LIMITED continues to expand its footprint in the industry.
Track SAI LIFE SCIENCES LIMITED Share Price on Univest
Use SAI LIFE SCIENCES LIMITED (SAILIFE) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Investors can track the live share price of SAI LIFE SCIENCES LIMITED on Univest, along with technical indicators, fundamental ratios, shareholding patterns, 52-week levels, and market insights. Univest provides comprehensive tools for investors to stay informed about market trends and company performance.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
What is the current share price of SAI LIFE SCIENCES LIMITED?
Ans. The current share price of SAI LIFE SCIENCES LIMITED is Rs 1,384.95, marking a 1.51% increase today and reaching a fresh 52-week high of Rs 1,387. The stock moved 1.51% during the session.
How does SAI LIFE SCIENCES LIMITED's P/E ratio compare to the sector?
Ans. SAI LIFE SCIENCES LIMITED's P/E ratio is 30.21, which is above the sector median of 21.71 but below the sector average of 71.67, indicating a relatively higher valuation. The company trades at a P/E ratio of 30.21x.
What is the market capitalisation of SAI LIFE SCIENCES LIMITED?
Ans. The market capitalisation of SAI LIFE SCIENCES LIMITED is Rs 28,266.01 crore, reflecting its significant presence in the healthcare sector. The company operates in the Healthcare sector. Its P/E ratio is 30.21x.
How does SAI LIFE SCIENCES LIMITED's P/B ratio compare to the sector?
Ans. SAI LIFE SCIENCES LIMITED's P/B ratio is 0.44, significantly lower than the sector median of 1.9, suggesting potential undervaluation relative to its book value. The company trades at a P/E ratio of 30.21x.
What are the ROE and ROCE of SAI LIFE SCIENCES LIMITED?
Ans. SAI LIFE SCIENCES LIMITED has an ROE of -2.89% and a ROCE of -0.26%, both below the sector medians of 10.75% and 13.29%, indicating challenges in profitability and capital efficiency.
How does SAI LIFE SCIENCES LIMITED compare to its peers?
Ans. SAI LIFE SCIENCES LIMITED has a larger market cap compared to peers like Kwality Pharmaceuticals and Beta Drugs but faces profitability challenges with lower ROE and ROCE. Comparable listed companies include Dishman Carbogen Amcis Ltd., Kwality Pharmaceuticals Ltd., Beta Drugs.
What is the significance of SAI LIFE SCIENCES LIMITED's 52-week high?
Ans. The 52-week high of Rs 1,387 signifies strong upward momentum and increased investor interest in SAI LIFE SCIENCES LIMITED, reflecting positive market sentiment. The stock moved 1.51% during the session.
